Sandesh Mahatme - May 30, 2024 Form 3 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Director
Signature
/s/ Sandesh Mahatme
Stock symbol
CRSP
Transactions as of
May 30, 2024
Transactions value $
$0
Form type
3
Date filed
5/30/2024, 04:27 PM
Previous filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRSP Stock Option (Right to Buy) May 30, 2024 Common Shares 26K $44.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on October 16, 2023 with respect to 26,000 Common Shares. 100% of the shares will vest in 36 equal monthly installments, with the first vesting date of November 16, 2023.

Remarks:

Exhibit 24 - Power of Attorney